Antimicrobial Ointments and Methicillin-Resistant Staphylococcus aureus USA300
Masahiro Suzuki
, Kazuhiro Yamada, Miki Nagao, Etsuko Aoki, Masakado Matsumoto, Tatsuya Hirayama, Hiroaki Yamamoto, Reiji Hiramatsu, Satoshi Ichiyama, and Yoshitsugu Iinuma
Author affiliations: Author affiliations: Aichi Prefectural Institute of Public Health, Nagoya, Japan (M. Suzuki, K. Yamada, M. Matsumoto, T. Hirayama, H. Yamamoto, R. Hiramatsu); Kyoto University Hospital, Kyoto, Japan (M. Nagao, S. Ichiyama, Y. Iinuma); Kyoto University, Kyoto (M. Nagao, S. Ichiyama, Y. Iinuma); National Hospital Organization Nagoya Medical Center, Nagoya (E. Aoki); Kanazawa Medical University, Kahoku, Japan (Y. Iinuma)
Main Article
Figure
Figure. Double-disk synergy test with 3 disks, bacitracin (B10 disk), neomycin (N30 disk), or polymyxin B (PL-B, PB300 disk) was performed with USA300 strain ATCC BAA1717. Disks were placed at 6 mm (A), 9 mm (B), and 11 mm (C) distance from disk centers. Neomycin and PL-B were found to be weakly synergistic.
Main Article
Page created: September 22, 2011
Page updated: September 22, 2011
Page reviewed: September 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.